Millrace Asset Group’s CareDx CDNA Stock Holding History

Millrace Asset Group’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-31,920	Closed	-$1.21M	–	80
2020 Q3	$1.21M	Sell	31,920 -11,049	-26%	-$373K	0.98%	53
2020 Q2	$1.52M	Sell	42,969 -26,399	-38%	-$751K	1.56%	26
2020 Q1	$1.51M	Buy	69,368 +2,458	+4%	+$55.1K	2.29%	9
2019 Q4	$1.44M	Buy	66,910 +39,500	+144%	+$906K	1.57%	33
2019 Q3	$620K	Sell	27,410 -3,590	-12%	-$99.4K	0.73%	58
2019 Q2	$1.12M	Sell	31,000 -6,600	-18%	-$211K	1.15%	50
2019 Q1	$1.19M	Sell	37,600 -37,400	-50%	-$1.09M	1%	55
2018 Q4	$1.89M	Sell	75,000 -33,400	-31%	-$858K	1.73%	23
2018 Q3	$3.13M	Sell	108,400 -91,600	-46%	-$1.71M	2.44%	7
2018 Q2	$2.45M	Sell	200,000 -100,000	-33%	-$1.15M	1.87%	16
2018 Q1	$2.39M	Buy	+300,000	New	+$1.85M	2.32%	13

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millrace Asset Group's CDNA Position: Q4 2020 in Review

Millrace Asset Group sold out of CareDx (CDNA) in Q4 2020, closing a stake of 31,920 shares — an estimated $1.21M sold.

Millrace Asset Group first reported a position in CDNA in Q1 2018 and held it in 11 quarters. The position peaked at $3.13M in Q3 2018. 232 funds tracked by Wall St. Rank hold CDNA as of Q4 2020.

Millrace Asset Group reported no remaining CareDx position as of Q4 2020 after selling out during the quarter.
Millrace Asset Group sold 31,920 CareDx shares in Q4 2020, an estimated $1.21M.
Millrace Asset Group first reported a position in CareDx in Q1 2018 and held it in 11 quarters.
Millrace Asset Group's CareDx position peaked at $3.13M in Q3 2018.
232 funds tracked by Wall St. Rank held CareDx as of Q4 2020.

Based on Millrace Asset Group's 13F filing for Q4 2020, filed 11 Feb 2021.